Here’s a tip for the AKT component of the MRCGP exam. The Royal College have said that they will be using the latest UKMEC contraception guidelines. The latest guidelines came out in 2016.
Here are a summary of a few of the changes:
- The first is that women can now use combined hormonal contraception if breastfeeding from six weeks.
- The other thing now is that combined hormonal contraception is contraindicated in patients with SLE and positive antiphospholipid antibodies. It is not the case in patients with negative phospholipid antibodies but it’s contraindicated in those who are positive.
- Another tip from UKMEC 2016 is the change with DMPA and levonorgestrel IUS. The effectiveness isn’t reduced by enzyme inducing drugs.
- Here’s another change in the UKMEC contraception guidelines 2016, this relates to family history of breast cancer and the BRCA mutation. These risk factors are not the same and are not treated the same. A family history of breast cancer is now a category 1, which means that patients can have combined hormonal contraception. However if a patient has the BRCA 1 mutation, then it’s a category 3. The disadvantages outweigh the advantages.
Contraception questions always crop up in the AKT examination, so make sure you visit the UKMEC site to look at the very latest guidelines and if you’d like to see a summary of the changes, then BMJ Learning have a video on that you can visit.
Contraception UKMEC - More Info for MRCGP AKT Exam Revision